Successful pregnancy outcome in a patient with Fabry disease receiving enzyme replacement therapy with agalsidase alfa

By Wendt S.   Whybra C.   Kampmann C.   Teichmann E.   Beck M.  

Journal of Inherited Metabolic Disease, Vol. 28, Iss. 5, 2005-09 ,pp. : 787-788

Springer Publishing Company

Access to resources Recommend Favorite

Enzyme replacement therapy in Fabry disease

By Brady R.   Murray G.   Moore D.   Schiffmann R.  

Journal of Inherited Metabolic Disease, Vol. 24, Iss. 2, 2001-04 ,pp. : 18-24

Springer Publishing Company

Access to resources Recommend Favorite

Hearing loss in a family affected by Fabry disease

By Sergi Bruno   Conti Guido  

Journal of Inherited Metabolic Disease, Vol. 30, Iss. 3, 2007-06 ,pp. : 370-374

Springer Publishing Company

Access to resources Recommend Favorite

Relief of gastrointestinal symptoms under enzyme replacement therapy in patients with Fabry disease

By Dehout F.   Roland D.   de Granseigne S.   Guillaume B.   Van Maldergem L.  

Journal of Inherited Metabolic Disease, Vol. 27, Iss. 4, 2004-07 ,pp. : 499-505

Springer Publishing Company

Access to resources Recommend Favorite

Monitoring enzyme replacement therapy in Fabry disease—Role of urine globotriaosylceramide

By Whitfield P.   Calvin J.   Hogg S.   O’Driscoll E.   Halsall D.   Burling K.   Maguire G.   Wright N.   Cox T.   Meikle P.   Deegan P.  

Journal of Inherited Metabolic Disease, Vol. 28, Iss. 1, 2005-01 ,pp. : 21-33

Springer Publishing Company

Access to resources Recommend Favorite